Menopause Weight Gain: Evidence-Based Management Guide for Midlife Women
By Sarah Editor · May 30, 2026Read article →
Articles & Guides
Plain-language, clinician-reviewed articles on women’s hormonal health. Every guide carries a board-certified medical reviewer byline with public credentials and a last-reviewed date. Browse by topic below.
Most recent
Menopause (49)
Vaginal Dryness Treatment Options: An Evidence Guide for Menopause
A clinician-reviewed guide to vaginal dryness treatment options during and after menopause, covering moisturizers, lubricants, hormonal therapies, DHEA, ospemifene, and what current NAMS and ACOG guidance recommends.
By Sarah Editor · May 30, 2026Read article →
Testosterone for Women and Libido: What the Evidence Shows in 2026
Testosterone for women with low libido is supported by the 2019 Global Consensus Position Statement for postmenopausal HSDD. Transdermal physiologic dosing reduces sexually satisfying events versus placebo. Here's what the evidence shows and how to discuss it with a clinician.
By Sarah Editor · May 30, 2026Read article →
Telehealth Menopause by State: 2026 Coverage, Licensing & Provider Guide
A state-by-state look at telehealth menopause care in 2026 — covering provider availability, interstate licensure compacts, insurance and Medicaid telehealth parity, and how cash-pay clinics structure access.
By Sarah Editor · May 30, 2026Read article →
Perimenopause Sleep Problems: Causes, Patterns, and Evidence-Based Options
Why perimenopause sleep problems develop, how estrogen and progesterone fluctuations disrupt sleep architecture, and what evidence-based options women can discuss with a clinician.
By Sarah Editor · May 30, 2026Read article →
PCOS and Perimenopause Overlap: How to Tell Symptoms Apart in 2026
A clinician-reviewed guide to PCOS perimenopause overlap — shared symptoms, what shifts after 40, lab markers that help distinguish them, and how telehealth providers approach mixed presentations.
By Sarah Editor · May 30, 2026Read article →
Online HRT Prescription Process: How Virtual Menopause Care Works
A plain-English walkthrough of the online HRT prescription process: who qualifies for virtual care, what the intake asks, how clinicians screen risk, pharmacy options, and what follow-up looks like across major telehealth providers.
By Sarah Editor · May 30, 2026Read article →
Perimenopause Mood Swings: Why They Happen and Evidence-Based Treatment Options
Perimenopause mood swings affect 40-70% of women during the menopausal transition, driven by fluctuating estradiol, sleep disruption, and prior depression history. This guide reviews evidence-based options from SSRIs and CBT to hormone therapy.
By Sarah Editor · May 30, 2026Read article →
Low Libido in Perimenopause: Causes, Evidence-Based Treatment Options
Low libido in perimenopause affects up to 40% of women aged 40-55. Causes span declining estradiol, testosterone shifts, vaginal dryness (GSM), sleep disruption, and SSRIs. This guide synthesizes NAMS, ISSWSH, and ACOG evidence on treatment options.
By Sarah Editor · May 30, 2026Read article →
Menopause Joint Pain: Causes, Evidence, and Treatment Options
Menopause joint pain — sometimes called the menopausal arthralgia syndrome — affects roughly half of women in the transition. Here's what current evidence shows about estrogen, inflammation, and what helps.
By Sarah Editor · May 30, 2026Read article →
HRT Insurance Coverage by State: A 2026 Guide for Menopause Care
How HRT insurance coverage varies state to state in 2026 — Medicaid formularies, ACA marketplace rules, telehealth parity laws, and what's typically paid vs. cash-pay for menopause hormone therapy.
By Sarah Editor · May 30, 2026Read article →
Hot Flashes Treatment: Evidence-Based Options for Menopause and Night Sweats
A clinician-reviewed look at hot flashes treatment — from hormone therapy and the new neurokinin-3 antagonists to lifestyle changes, telehealth access, and cost. Discuss any approach with a qualified clinician.
By Sarah Editor · May 30, 2026Read article →
Hormonal IUD in Perimenopause: Contraception, Bleeding & HRT Use
A hormonal IUD in perimenopause does three things at once: prevents pregnancy (still possible until 12 months amenorrhea), reduces heavy bleeding by up to 90%, and provides endometrial protection if you add estrogen. Here's what the evidence shows.
By Sarah Editor · May 30, 2026Read article →
Hormonal Migraines in Perimenopause: Causes, Triggers, and Options
Hormonal migraines frequently intensify during perimenopause as estradiol levels swing unpredictably. Here's what current evidence shows about estrogen withdrawal, aura risk, and the options worth discussing with a clinician.
By Sarah Editor · May 30, 2026Read article →
Perimenopause Heart Palpitations: Causes, Patterns, and When to Seek Care
Heart palpitations during perimenopause are common but unsettling. Estrogen fluctuations, autonomic shifts, and overlapping triggers explain most episodes — here is what the research shows and how clinicians evaluate them.
By Sarah Editor · May 30, 2026Read article →
Estrogen Osteoporosis Prevention: Evidence, Timing, and Bone Health Options
Estrogen withdrawal at menopause triggers rapid bone loss. Here's what the evidence shows about estrogen osteoporosis prevention, the timing hypothesis, alternatives, and how to weigh options with a clinician.
By Sarah Editor · May 30, 2026Read article →
Menopause Dry Skin and Collagen Loss: Causes, Evidence, Options
Menopause dry skin and collagen loss accelerate sharply in the first five postmenopausal years — women lose roughly 30% of skin collagen. Here's what current evidence shows about why, and which interventions have data.
By Sarah Editor · May 30, 2026Read article →
How to Choose a Menopause Telehealth Provider: An Editorial Buyer's Guide
How to choose menopause telehealth comes down to seven factors: clinician credentials, state coverage, prescribing scope, lab handling, insurance model, communication cadence, and price transparency. This editorial guide walks through each.
By Sarah Editor · May 30, 2026Read article →
Vaginal Estrogen Safety and Use: Evidence Guide for Menopause
A clinician-reviewed guide to vaginal estrogen safety: how low-dose formulations work, what the evidence says about cancer and cardiovascular risk, and what to discuss with a provider.
By Sarah Editor · May 29, 2026Read article →
Perimenopause Symptoms Checklist: 34 Signs Women Should Track
A complete, evidence-based perimenopause symptoms checklist covering 34 hormonal, physical, vasomotor, and cognitive signs — with prevalence data, tracking tips, and when to see a clinician.
By Sarah Editor · May 29, 2026Read article →
HRT vs Non-Hormonal Menopause Treatment: Evidence-Based Comparison
A side-by-side look at HRT vs non-hormonal menopause options — covering hot-flash relief rates, contraindications, cost ranges, and telehealth provider differentiators for cash-pay vs insurance-covered care.
By Sarah Editor · May 29, 2026Read article →
GLP-1 and Menopause Weight Loss: What the Research Shows in 2026
How GLP-1 medications like semaglutide and tirzepatide perform for midlife weight gain — clinical data, side effects, drug interactions with HRT, and what to discuss with a clinician.
By Sarah Editor · May 29, 2026Read article →
Preparing for your first telehealth menopause visit
Thirty minutes of prep before your first telehealth menopause visit saves weeks of back-and-forth dose tuning. Here's the checklist that gets you to a working regimen faster.
By Sarah Editor · May 16, 2026Read article →
Mood swings vs depression in perimenopause: how to tell them apart
Perimenopausal mood changes, PMDD, and major depression overlap in symptoms but respond to different treatments. The diagnostic distinctions matter.
By Sarah Editor · May 16, 2026Read article →
Brain fog in perimenopause: what's real, what's reversible
Perimenopausal brain fog is documented in fMRI and cognitive testing. It's usually reversible — but the conditions that mimic it must be ruled out.
By Sarah Editor · May 16, 2026Read article →
Hot flashes: causes, mechanism, and what actually helps
Hot flashes affect 75–80% of women across the menopause transition. The mechanism is now reasonably well understood — and that understanding shapes what works.
By Sarah Editor · May 16, 2026Read article →
Perimenopause stages: what to expect across the transition
Perimenopause is a 5–10 year transition with predictable phases. Knowing which symptoms typically appear when reduces the "is this normal?" anxiety.
By Sarah Editor · May 16, 2026Read article →
FSH testing in perimenopause: when it helps and when it misleads
FSH testing is widely ordered for perimenopause but the single value fluctuates so much it usually misleads. Knowing the test's limits prevents wasted appointments.
By Sarah Editor · May 16, 2026Read article →
Topical vs oral NSAIDs for menopausal joint pain
Topical diclofenac is now OTC and reaches therapeutic synovial levels with 90% less systemic exposure than oral NSAIDs. First-line for localized joint pain.
By Sarah Editor · May 15, 2026Read article →
Glucosamine and collagen supplements: separating evidence from marketing
Glucosamine has modest evidence in OA. Collagen peptides show small benefit in some trials. Neither is a substitute for resistance exercise + nutrition basics.
By Sarah Editor · May 15, 2026Read article →
Exercise protocols that help menopausal joint pain (and what makes it worse)
Low-impact high-resistance training improves joint stability and pain scores. Long-distance running and high-intensity plyometrics often worsen midlife arthralgia.
By Sarah Editor · May 15, 2026Read article →
Why is frozen shoulder so common в menopause?
Adhesive capsulitis disproportionately affects women 40-60 — coinciding с estrogen decline. Recent reviews suggest estrogen replacement may aid recovery.
By Sarah Editor · May 15, 2026Read article →
Menopausal joint pain vs rheumatoid arthritis: differential diagnosis
Both present с morning stiffness in midlife women. Pattern of joints, lab markers (RF, CCP), and response to NSAIDs distinguish them. Don't miss treatable RA.
By Sarah Editor · May 15, 2026Read article →
Estrogen receptors in joints: why menopause causes stiffness
ERα and ERβ receptors in cartilage, ligaments, and synovium drive joint maintenance. Estrogen withdrawal accelerates degenerative changes — measurable on MRI.
By Sarah Editor · May 15, 2026Read article →
Testosterone for women: realistic side effects timeline
Acne and increased body hair are most common at higher doses. Voice changes and clitoral enlargement are rare but irreversible. Monitoring protocols.
By Sarah Editor · May 15, 2026Read article →
Libido changes after hysterectomy: ovary-sparing vs total
Removing ovaries causes immediate surgical menopause; uterus-only removal preserves natural hormone production but can still affect libido through other pathways.
By Sarah Editor · May 15, 2026Read article →
Pelvic floor dysfunction: the underdiagnosed libido issue
Pelvic floor tightness causes pain with intercourse, which extinguishes desire. Pelvic floor PT often resolves underlying physical barrier before medication.
By Sarah Editor · May 15, 2026Read article →
Flibanserin vs bremelanotide: comparing FDA-approved HSDD drugs
Both are FDA-approved for premenopausal HSDD but differ dramatically. Daily oral SSRI-adjacent vs on-demand injection. Side effects, efficacy, and patient fit.
By Sarah Editor · May 15, 2026Read article →
Can women take testosterone safely?
Despite no FDA-approved testosterone formulation for women, off-label transdermal testosterone has strong evidence for hypoactive sexual desire disorder в postmenopausal women.
By Sarah Editor · May 15, 2026Read article →
Vaginal estrogen: low-dose, low-systemic, high-impact
Topical estradiol creams, rings, and tablets restore vaginal tissue without significant systemic absorption. First-line for genitourinary syndrome of menopause.
By Sarah Editor · May 15, 2026Read article →
Effective mood tracking during menopause transition
Daily 1-line tracking beats weekly journaling. Correlate symptoms with cycle day, sleep score, and hot flash count to surface patterns clinicians can act on.
By Sarah Editor · May 15, 2026Read article →
Iron deficiency and perimenopausal mood: the missing workup
Heavy perimenopausal periods drive iron loss often missed in standard labs. Low ferritin (under 50 ng/mL) correlates с fatigue, anxiety, and ADHD-like symptoms.
By Sarah Editor · May 15, 2026Read article →
SSRI vs SNRI for menopausal mood and hot flashes
Venlafaxine and desvenlafaxine have stronger hot flash evidence; paroxetine and escitalopram win on mood-first profiles. Choosing for dual-action benefit.
By Sarah Editor · May 15, 2026Read article →
PMDD worsening in perimenopause: what to do when symptoms intensify
Premenstrual dysphoric disorder often gets worse before improving in perimenopause. SSRIs, ovulation suppression, and HRT have different best-fit profiles.
By Sarah Editor · May 15, 2026Read article →
How estrogen drives mood: the neurobiology explained
Estrogen modulates serotonin, dopamine, and noradrenaline synthesis and receptor sensitivity. Fluctuation — not just level — drives perimenopausal mood instability.
By Sarah Editor · May 15, 2026Read article →
Is perimenopausal depression different от regular depression?
Perimenopausal depression has distinct features: tied to hormone fluctuation, often responsive to estradiol, more variable presentation. Diagnostic frameworks clinicians use.
By Sarah Editor · May 15, 2026Read article →
Could your "menopause insomnia" actually be sleep apnea?
Estrogen protects against upper airway collapse. After menopause, sleep apnea prevalence in women catches up to men. Symptoms differ — fatigue vs snoring.
By Sarah Editor · May 15, 2026Read article →
CBT-I outperforms sleep medication long-term — even in menopause
Cognitive behavioral therapy for insomnia produces durable improvements unlike Z-drugs or benzodiazepines. Online programs make it accessible.
By Sarah Editor · May 15, 2026Read article →
How does perimenopause change your sleep?
Slow-wave sleep declines, REM fragmentation increases, and arousal threshold drops. Beyond just "more night wakings" — measurable changes in PSG studies.
By Sarah Editor · May 15, 2026Read article →
HRT (17)
Progesterone Types Compared: Micronized, Synthetic Progestins & Compounded Options
Not all progesterone is the same. Compare micronized progesterone, synthetic progestins, progestin IUDs, and compounded options on evidence, breast cancer risk, sleep effects, and how telehealth menopause clinics prescribe them.
By Sarah Editor · May 30, 2026Read article →
HRT Cognitive Benefits: What the Evidence Says About Brain Fog and Dementia Risk
HRT cognitive benefits remain one of the most contested areas in menopause medicine. This evidence guide synthesizes WHIMS, KEEPS, ELITE, and 2023-2024 cohort data on perimenopausal brain fog, timing-of-initiation effects, and long-term dementia risk.
By Sarah Editor · May 30, 2026Read article →
HRT Blood Clots Risk: What the Evidence Shows About VTE and Hormone Therapy
The HRT blood clots risk varies sharply by route, formulation, age, and personal history. Transdermal estradiol shows little to no extra venous thromboembolism risk in large database studies, while oral formulations roughly double it from a low baseline.
By Sarah Editor · May 30, 2026Read article →
HRT After Breast Cancer: Key Considerations for Symptom Management
HRT after breast cancer raises difficult questions for survivors managing menopause symptoms. This guide reviews the current evidence base, non-hormonal alternatives, and frameworks survivors use when discussing care with oncology and menopause clinicians.
By Sarah Editor · May 30, 2026Read article →
Estradiol Patch vs Pill: How Transdermal and Oral HRT Compare
Estradiol patch vs pill — transdermal delivery bypasses first-pass liver metabolism and carries a lower venous thromboembolism signal, while oral estradiol is cheaper and well-studied. Here is how the two compare on efficacy, safety, and cost.
By Sarah Editor · May 30, 2026Read article →
Compounded vs FDA HRT: Evidence, Safety, and Cost Comparison
Compounded vs FDA HRT differ in regulation, evidence base, dosing accuracy, and out-of-pocket cost. Here is what current guidelines from NAMS, ACOG, and the FDA say — and how telehealth menopause clinics typically prescribe.
By Sarah Editor · May 30, 2026Read article →
Progesterone Side Effects in Women: Complete Evidence-Based Guide
An evidence-based breakdown of progesterone side effects women report most often during HRT and luteal-phase use, including timeline, dose dependency, and what warrants a clinical conversation.
By Sarah Editor · May 29, 2026Read article →
How Much Does HRT Cost Without Insurance? 2026 Price Guide
A 2026 breakdown of cash-pay HRT pricing: estradiol patches, oral progesterone, telehealth visits, and compounded options. Typical out-of-pocket runs $15-$200/month before discount cards.
By Sarah Editor · May 29, 2026Read article →
Estradiol Side Effects in Women: Complete Guide to Risks and Symptoms
Estradiol side effects range from mild breast tenderness and bloating in 10-30% of users to rare but serious risks like venous thromboembolism. Here's what the evidence says and what to discuss with your clinician.
By Sarah Editor · May 29, 2026Read article →
Bioidentical Hormones Explained: Evidence, Risks, and Modern HRT Options
Bioidentical hormones are chemically identical to those the body produces. Here's what current evidence says about FDA-approved versus compounded options, safety, costs, and how telehealth providers prescribe them.
By Sarah Editor · May 29, 2026Read article →
Red flags when choosing a telehealth HRT or GLP-1 provider
Most telehealth brands deliver real care. A small minority cut clinical corners or hide important information. Here are the red flags worth walking away over.
By Sarah Editor · May 16, 2026Read article →
Telehealth vs in-person HRT: when each works best
Telehealth HRT has become clinically robust. In-person care still has specific advantages — knowing when each fits prevents both unnecessary clinic visits and inappropriate telehealth dependence.
By Sarah Editor · May 16, 2026Read article →
How to start HRT: the practical first 90 days
The first 90 days on HRT settle the question of whether it's working and tolerable. Knowing what to expect prevents premature discontinuation.
By Sarah Editor · May 16, 2026Read article →
Compounded vs FDA-approved HRT: what the difference actually means
Compounded hormone therapy is widely marketed but not FDA-approved. The active molecules can be identical to FDA versions — but regulation, dose accuracy, and safety oversight differ.
By Sarah Editor · May 16, 2026Read article →
HRT eligibility: who qualifies and who doesn't
HRT eligibility is broader than most women assume. The actual absolute contraindications are few; most "I was told I can't take it" is outdated guidance.
By Sarah Editor · May 16, 2026Read article →
Estradiol vs estrone vs estriol: the three estrogens explained
Estradiol, estrone, and estriol are the three main human estrogens. Each dominates at a different life stage. Knowing which matters when changes how you read your labs.
By Sarah Editor · May 16, 2026Read article →
Micronized progesterone for sleep: more than HRT
Oral progesterone converts to allopregnanolone, a GABA-A agonist with sleep-promoting effects. Bedtime dosing maximizes sleep benefit independent of menopause status.
By Sarah Editor · May 15, 2026Read article →
PCOS (16)
Hair Thinning in Women: Hormonal Causes and Evidence-Based Options
A clinician-reviewed explainer on hormonal hair thinning in women — androgenetic alopecia, menopause shedding, thyroid links, PCOS, telehealth providers, costs, and red flags.
By Sarah Editor · May 30, 2026Read article →
Spironolactone Side Effects in Women: A Complete Evidence-Based Guide
A detailed editorial review of spironolactone side effects in women — frequency data, dose-dependent risks, drug interactions, and what monitoring labs to discuss with a clinician.
By Sarah Editor · May 29, 2026Read article →
Metformin Side Effects in Women: A Comprehensive Guide for PCOS and Beyond
An evidence-based editorial overview of metformin side effects in women — gastrointestinal symptoms, vitamin B12 depletion, PCOS-specific considerations, and how telehealth providers approach tolerability monitoring.
By Sarah Editor · May 29, 2026Read article →
Letrozole Side Effects in PCOS Fertility Treatment: A Complete Guide
Letrozole (Femara) is first-line for PCOS ovulation induction, but side effects from hot flashes to fatigue affect roughly 1 in 3 users. Here's what the trials show and how it compares to clomid.
By Sarah Editor · May 29, 2026Read article →
Hormonal Acne Treatment for Women: Evidence-Based Options in 2026
A clinician-reviewed guide to hormonal acne treatment for women — covering spironolactone, combined oral contraceptives, topical options, telehealth providers, costs, and red flags.
By Sarah Editor · May 29, 2026Read article →
Clomid Side Effects: Complete Guide to Risks, Frequency & Management
An evidence-based look at Clomid side effects — from common hot flashes (10-20% of users) to rare but serious risks like OHSS and visual disturbances. What the data says and when to involve a clinician.
By Sarah Editor · May 29, 2026Read article →
Hormonal acne and PCOS: when adult acne is actually endocrinology
Adult-onset hormonal acne in women — particularly along the jawline — is often the first visible sign of PCOS. Topical-only treatment misses the underlying driver.
By Sarah Editor · May 16, 2026Read article →
PCOS medications compared: metformin vs spironolactone vs GLP-1 vs OCP
Four primary PCOS medication classes — metformin, spironolactone, GLP-1, hormonal contraception — each target different aspects. The right choice depends on phenotype and priorities.
By Sarah Editor · May 16, 2026Read article →
Rotterdam criteria: how PCOS is actually diagnosed
PCOS diagnosis uses the Rotterdam criteria — two of three features required. The criteria are widely misapplied; clarifying them reduces false labels.
By Sarah Editor · May 16, 2026Read article →
PCOS is four conditions, not one: the phenotype framework
PCOS is not one disease. Four phenotypes — insulin-resistant, inflammatory, adrenal, post-pill — explain why one woman's PCOS responds to metformin while another's doesn't.
By Sarah Editor · May 16, 2026Read article →
Pregnancy-safe acne treatments when hormones spike
Most acne medications are contraindicated в pregnancy. Azelaic acid, low-dose glycolic acid, and benzoyl peroxide remain safe options для hormonally-triggered acne.
By Sarah Editor · May 15, 2026Read article →
Tretinoin vs tazarotene for hormonal acne
Both topical retinoids treat hormonal acne but differ in potency, irritation profile, and pregnancy category. Selection by skin type and tolerance.
By Sarah Editor · May 15, 2026Read article →
Isotretinoin for women: pregnancy prevention and side effects
iPLEDGE requirements, dual contraception, and monthly labs make isotretinoin a significant commitment. Effects on mood, joints, and lipids that need monitoring.
By Sarah Editor · May 15, 2026Read article →
PCOS-driven acne: combined treatment protocol
PCOS hyperandrogenism requires combined approach: spironolactone for receptor blockade, combined OCP or metformin for upstream hormonal management.
By Sarah Editor · May 15, 2026Read article →
Spironolactone for hormonal acne: dosing, monitoring, expectations
Starting at 25-50mg, titrating to 100-200mg. Effect timeline (3-6 months), potassium monitoring frequency, and managing common side effects.
By Sarah Editor · May 15, 2026Read article →
Why is my acne suddenly along my jawline?
Deep cystic lesions along jawline and chin — especially worsening premenstrual — strongly suggest hormonal driver. Testing protocols and treatment paths.
By Sarah Editor · May 15, 2026Read article →
GLP-1 (9)
Tirzepatide Side Effects in Women: What Research Shows
Tirzepatide side effects in women span from common GI symptoms (nausea in 28-44%) to less-discussed effects on menstrual cycles, hormonal contraception, and bone health. Here's what peer-reviewed evidence shows.
By Sarah Editor · May 29, 2026Read article →
Semaglutide Side Effects in Women: A Complete 2026 Guide
A clinician-reviewed look at semaglutide side effects women report most often — from nausea and constipation to menstrual shifts, hair shedding, and oral contraceptive interactions — plus what the trial data and FDA labels actually say.
By Sarah Editor · May 29, 2026Read article →
GLP-1 insurance coverage: navigating the reality in 2026
GLP-1 insurance coverage in 2026 varies wildly by plan, indication, and state. Knowing the landscape before you start saves months of denied claims.
By Sarah Editor · May 16, 2026Read article →
GLP-1 side effects in women: what to expect and what to call about
GLP-1 side effects are common but mostly mild and time-limited. Knowing the typical 8-week trajectory prevents premature discontinuation — and helps distinguish normal from warning.
By Sarah Editor · May 16, 2026Read article →
Compounded vs branded GLP-1: semaglutide, Wegovy, tirzepatide, Zepbound
Compounded semaglutide and tirzepatide cost a fraction of branded Wegovy or Zepbound. The trade-offs in oversight, dose accuracy, and supply uncertainty matter.
By Sarah Editor · May 16, 2026Read article →
GLP-1 medications for perimenopausal weight gain
Perimenopausal weight gain has a metabolic basis that calorie restriction often can't address. GLP-1 medications target the underlying insulin resistance directly.
By Sarah Editor · May 16, 2026Read article →
What happens when you stop taking GLP-1?
STEP-4 trial showed two-thirds of weight regained within a year of stopping semaglutide. Maintenance dosing and lifestyle integration matter more than starting dose.
By Sarah Editor · May 15, 2026Read article →
How insurance covers GLP-1 for women in 2026
Coverage policies fluctuated dramatically in 2024-2025. We map current major payer rules for Wegovy, Zepbound, and PA requirements.
By Sarah Editor · May 15, 2026Read article →
Sarcopenia: the muscle loss problem behind menopausal weight gain
Women lose 3-8% muscle per decade after 30, accelerating in menopause. Without resistance training, weight loss diets can worsen the underlying problem.
By Sarah Editor · May 15, 2026Read article →
Perimenopause (2)
How much melatonin should women take?
Physiologic-dose melatonin (0.1-0.5mg) outperforms pharmacologic doses for circadian timing. Higher doses cause next-day grogginess without sleep benefit.
By Sarah Editor · May 15, 2026Read article →
Low-dose doxepin for menopausal insomnia: the underused option
At 3-6mg (vs 100-300mg antidepressant doses), doxepin acts as a selective H1 antagonist promoting sleep maintenance without dependency or hangover.
By Sarah Editor · May 15, 2026Read article →
More editorial (7)
- PMDD vs PMS: Key Differences, Symptoms & Diagnosis Explained· May 29, 2026
- Hot Flashes Treatment: Evidence-Based Options for Menopausal Women· May 29, 2026
- Hormone Testing Accuracy: Blood vs Saliva vs Urine Compared· May 29, 2026
- How we score brands: the full methodology behind the composite· May 16, 2026
- The WHI study, properly contextualized: what 2002 said, what we know now· May 16, 2026
- Bioidentical vs synthetic hormones: what the labels actually mean· May 16, 2026
- STRAW+10 reproductive staging explained· May 16, 2026